Hamburg, Germany – Sysmex Inostics, a subsidiary of Sysmex Corporation and a global leader in blood-based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology, announces the launch of the OncoBEAM™ EGFR Kit v2 for research use only in Europe and Asia. OncoBEAM™ EGFR Kit v2 replaces the EGFR v1 kit and joins Sysmex […]
Basel, Switzerland Genedata, a leading provider of advanced software solutions for life science research and development, and Bayer, today announced the extension of their long-term partnership. Genedata supports Bayer’s Crop Science division to digitalize R&D processes and this extended partnership now includes a license to the Genedata Selector® platform to support Bayer’s global discovery process and data […]
MINNEAPOLIS — Bio-Techne, a global leader of research and manufacturing-grade reagents, has announced a corporate initiative to advance cell and gene therapy research and ex vivo cell processing. Through strategic acquisitions and internal scientific innovation, Bio-Techne has become uniquely positioned to provide a comprehensive, innovative, and flexible set of reagents and instrumentation across the cell and gene […]
Global investment firm backs growth plans for TTP Labtech Cambridge, UK: TTP Labtech Ltd, an international leader in the design and development of automated instrumentation and consumables for life science research is pleased to announce that investment from Battery Ventures has underpinned their aggressive growth plans. Over the last 18 years TTP Labtech has successfully […]
New enterprise brings together cutting-edge technologies in Genetic Testing from Ambry, Konica Minolta’s Imaging, and AI-technology from Invicro, to fight diseases including cancer and Alzheimer’s Offering fully-fledged precision medicine services to pharmaceutical companies, academia and medical institutions/hospitals in Japan Tokyo – Konica Minolta, Inc. (“Konica Minolta”) (TOKYO: 4902; ISIN: JP3300600008) today announced the launch of […]
On September 26, 2018, BGI and Maxwell Plus executed a collaborative research project “A model to predict the risk of developing advanced or metastatic prostate cancer using genetic makeup and family history of cancers”. Prostate cancer is the second most common type of cancer among males in Western countries, with an estimated 165,000 new cases and 29,500 […]
STONY BROOK N.Y. – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) announced today that it is launching an additional system to tag the industry’s larger volume cannabis or hemp grows as part of TheraCann International’s ETCH Biotrace™ solution. On the heels of its successful showing of its first Cannabis Tagging System (CTS) in July […]
Probes for CGI’s FISH-based HPV-Associated Cancer Test (FHACT®) test to be manufactured by Agilent RUTHERFORD, N.J. — Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today announced that it has signed a non-exclusive supply agreement with Agilent Technologies Inc. through which Agilent will […]
Important research collaboration for pioneering PRS approach to help drug developers running clinical trials identify and stratify between slow and rapid progressors of the disease Oxford & Manchester, UK. Cytox, a precision medicine company which today is commercializing polygenic risk scoring (PRS) approaches for assessing genetic risk for developing Alzheimer’s and other neurological diseases, has announced […]
First-to-market cell line-derived reference standard for myeloid blood cancers Largest cell-line derived reference standard available, contains 22 mutations across 19 oncology-relevant genes Enables faster, more reliable and more cost-effective assay validation Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
